Chronic Schizophrenia
Neurology
3
Pipeline Programs
2
Companies
2
Clinical Trials
1
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket
On Market (1)
Approved therapies currently available
U
OXYGEN, USPApproved
oxygen
Unknown Companyinhalation2018
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticalsoxygen
Newron PharmaceuticalsNW-3509A
Clinical Trials (2)
Total enrollment: 20 patients across 2 trials
Oxygen Therapy in Schizophrenia
Start: Jan 2008Est. completion: Dec 200920 patients
Phase 3Unknown
A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
Start: Dec 2015Est. completion: Jan 2017
Phase 2Completed
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
13h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
13h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
13h ago
Director of Finance
CoMind
London, UK
13h ago
Electronics Engineering Manager
CoMind
London, UK
13h ago
Director of Information Technology
Zavation Medical Products
13h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space